Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 124682142 | 12468214 | 2 | F | 20160523 | 20160729 | 20160615 | 20160804 | EXP | PHHY2016NL081859 | NOVARTIS | 74.76 | YR | M | Y | 0.00000 | 20160804 | MD | NL | NL |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 124682142 | 12468214 | 1 | PS | ZOMETA | ZOLEDRONIC ACID | 1 | Intravenous (not otherwise specified) | 1 DF, QMO EVERY 4 WEEKS | S0138, S0149A, S0149 | 21223 | 1 | DF | SOLUTION FOR INFUSION | /month | |||||
| 124682142 | 12468214 | 2 | C | ASA | ASPIRIN | 1 | Unknown | 80 MG, QD | U | 0 | 80 | MG | QD | ||||||
| 124682142 | 12468214 | 3 | C | PERSANTINE | DIPYRIDAMOLE | 1 | Unknown | 200 MG, BID | U | 0 | 200 | MG | BID | ||||||
| 124682142 | 12468214 | 4 | C | ELIGARD | LEUPROLIDE ACETATE | 1 | Unknown | 45 MG, EVERY HALF A YEAR | U | 0 | 45 | MG | |||||||
| 124682142 | 12468214 | 5 | C | SIMVASTATINE | SIMVASTATIN | 1 | Unknown | 40 MG, QD | U | 0 | 40 | MG | QD |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 124682142 | 12468214 | 1 | Hormone-dependent prostate cancer |
| 124682142 | 12468214 | 2 | Product used for unknown indication |
| 124682142 | 12468214 | 3 | Product used for unknown indication |
| 124682142 | 12468214 | 4 | Product used for unknown indication |
| 124682142 | 12468214 | 5 | Product used for unknown indication |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 124682142 | 12468214 | HO |
| 124682142 | 12468214 | OT |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 124682142 | 12468214 | Citrobacter infection | |
| 124682142 | 12468214 | Hormone-dependent prostate cancer | |
| 124682142 | 12468214 | Malignant neoplasm progression | |
| 124682142 | 12468214 | Sepsis | |
| 124682142 | 12468214 | Urinary tract infection | |
| 124682142 | 12468214 | Urinary tract obstruction | |
| 124682142 | 12468214 | Urosepsis |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|---|
| 124682142 | 12468214 | 1 | 20150518 | 0 | ||
| 124682142 | 12468214 | 4 | 2010 | 0 |